Close Menu

NEW YORK – Quest Diagnostics reported today that its second quarter revenues grew a little less than 2 percent year over year.

For the three months ended June 30, total revenues reached $1.95 billion, up from $1.92 billion a year ago, and beating the consensus Wall Street estimate of $1.94 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.